Pharmaceutical Contract Packaging Market Report 2026

Pharmaceutical Contract Packaging Market Overview

• Pharmaceutical Contract Packaging market size has reached to $34.1 billion in 2025 • Expected to grow to $50.75 billion in 2030 at a compound annual growth rate (CAGR) of 8.2% • Growth Driver: Pharmaceutical Contract Packaging Market Soars Amidst The Rise In Elderly Populations • Market Trend: Enhancing Flexibility And Productivity In Pharmaceutical Packaging • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Pharmaceutical Contract Packaging Market?

Pharmaceutical contract packaging is the most cost-effective way to present, protect, identify, provide information, make it convenient, ensure compliance, maintain the integrity of the product, and keep it stable. Packaging is very useful for identifying products and protecting those products from contamination. The main products of pharmaceutical contract packaging are primary packaging, secondary packaging, and tertiary packaging. Primary packaging is the packaging in direct contact with the product itself and is sometimes referred to as consumer or retail packaging. The materials are paper and paperboard, plastics and polymers, aluminum foil, glass, and other materials and are used in small molecules, biopharmaceuticals, and vaccines.

What Is The Pharmaceutical Contract Packaging Market Growth Forecast?

The pharmaceutical contract packaging market size is expected to see strong growth in the next few years. It will grow to $50.75 billion in 2030 at a compound annual growth rate (CAGR) of 8.2%. The growth in the forecast period can be attributed to growth of biopharmaceutical and vaccine production, increasing regulatory emphasis on serialization, rising demand for cold chain compatible packaging, expansion of global pharmaceutical supply chains, growing focus on patient centric packaging designs. Major trends in the forecast period include growing outsourcing of pharmaceutical packaging operations, rising demand for high quality blister and unit dose packaging, increasing focus on regulatory compliant packaging solutions, expansion of serialization and track and trace packaging, higher adoption of flexible and scalable contract packaging services.

Tariff Impact On Pharmaceutical Contract Packaging Market

Tariffs have affected the pharmaceutical contract packaging market by increasing the cost of imported packaging materials such as aluminum foils, plastics, glass containers, and specialized labeling components. These impacts have been most evident in primary and secondary packaging segments across North America, Europe, and Asia Pacific where cross border sourcing is common. Higher tariffs have raised packaging costs and pressured contract margins for service providers. At the same time, tariffs have encouraged local sourcing of materials, regional packaging operations, and investments in domestic packaging capabilities, supporting long term supply chain resilience.

Global Pharmaceutical Contract Packaging Market Segmentation

1) By Product: Primary Packaging, Secondary Packaging, Tertiary Packaging 2) By Material: Paper And Paperboard, Plastics And Polymers, Aluminum Foil, Glass, Other Materials 3) By Industry: Small Molecule, Biopharmaceutical, Vaccine Subsegments: 1) By Primary Packaging: Blister Packs, Bottles, Vials, Ampoules, Pre-Filled Syringes 2) By Secondary Packaging: Cartons, Labels, Inserts, Shrink Sleeves 3) By Tertiary Packaging: Shipping Containers, Pallets, Bulk Packaging Solutions

What Is The Driver Of The Pharmaceutical Contract Packaging Market?

Growth in the number of elderly populations is expected to propel the growth of the pharmaceutical contract packaging market going forward. The elderly population refers to people aged 65 and over. The aging population is driving manufacturers to develop packaging that is easier to open while remaining child-resistant, but this can increase costs and affect sustainability. For instance, in July 2024, according to the UK Parliament's House of Commons Library, a UK-based government administration, in 2022, there were 12.7 million individuals aged 65 or older in the UK, making up 19% of the total population. By 2072, this number is expected to increase to 22.1 million, comprising 27% of the population. Therefore, Growth in the number of elderly populations is driving the growth of the pharmaceutical contract packaging industry.

What Is The Driver Of The Pharmaceutical Contract Packaging Market?

Growth in the number of elderly populations is expected to propel the growth of the pharmaceutical contract packaging market going forward. The elderly population refers to people aged 65 and over. The aging population is driving manufacturers to develop packaging that is easier to open while remaining child-resistant, but this can increase costs and affect sustainability. For instance, in July 2024, according to the UK Parliament's House of Commons Library, a UK-based government administration, in 2022, there were 12.7 million individuals aged 65 or older in the UK, making up 19% of the total population. By 2072, this number is expected to increase to 22.1 million, comprising 27% of the population. Therefore, Growth in the number of elderly populations is driving the growth of the pharmaceutical contract packaging industry.

Global Pharmaceutical Contract Packaging Market Trends and Insights

Major companies operating in the pharmaceutical contract packaging market are focusing on developing innovative solutions, such as modular filling and capping platforms, to enhance efficiency, flexibility, and scalability in packaging operations. Modular filling and capping platforms are configurable systems that combine filling, capping, and quality control functions in one line, allowing manufacturers to quickly adapt to different products and container types, reduce setup time, save space, and improve overall production efficiency. For instance, in August 2025, Rotzinger PharmaPack, a Switzerland-based contract packaging company, launched the VarioFill platform, an innovative filling and capping solution designed for over-the-counter pharmaceuticals, cosmetic liquids and creams, and solid dosage forms such as tablets and capsules. VarioFill features a modular design that allows manufacturers to reconfigure or expand the platform with different modules for various product types, container shapes, and closure methods, achieving more than 50% space savings compared to conventional lines. The system integrates gentle transport using universal grippers, sealess rotary piston pumps for liquid dosing, tablet and capsule counters, and fully automated cleaning-in-place (CIP) functionality, ensuring product integrity and operational efficiency.

What Are Latest Mergers And Acquisitions In The Pharmaceutical Contract Packaging Market?

In September 2025, Praxis Packaging Solutions, a US-based healthcare technology and contract packaging company, acquired Advanced Concept Innovations, LLC for an undisclosed amount. With this acquisition, Praxis aims to expand its geographic footprint into the Southeastern United States and enhance its packaging capabilities across multiple healthcare and consumer markets. Advanced Concept Innovations, LLC is a US-based contract packaging company that specializes in providing packaging solutions for medical devices, over-the-counter products, consumer goods, health and beauty products, and domestic manufacturing of surgical N95 respirators.

Regional Outlook

North America was the largest region in the pharmaceutical contract packaging market in 2025. Asia-Pacific is expected to be the fastest-growing region in the pharmaceutical contract packaging market report during the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Pharmaceutical Contract Packaging Market?

The pharmaceutical contract packaging market includes revenues earned by entities in different categories, such as drug labelling and packaging. The services provided by a contract pharmaceutical packager include designing medicine packaging and testing the packed drug. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Pharmaceutical Contract Packaging Market Report 2026?

The pharmaceutical contract packaging market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the pharmaceutical contract packaging industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.